5G3M | Hydrolase | date | Apr 29, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Discovery Of A Novel Secreted Phospholipase A2 (Spla2) Inhib | ||||||||||||||
authors | J.Sandmark, C.Bodin, K.Hallberg | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Group 10 Secretory Phospholipase A2 Chain: A, B Fragment: Mature Spla2-X, Unp Residues 43-165 Synonym: Secreted Phospholipase A2, Group X Secretory Phosp Spla2-X, Phosphatidylcholine 2-Acylhydrolase 10; Ec: 3.1.1.4 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 469008 Expression_system_strain: Bl21(De3) Expression_system_variant: Gold Expression_system_plasmid: Pet24a | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.85 Å | ||||||||||||
ligand | 9JH, CA, DMS, PEG | enzyme | Hydrolase E.C.3.1.1.4 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease., Giordanetto F, Pettersen D, Starke I, Nordberg P, Dahlstrom M, Knerr L, Selmi N, Rosengren B, Larsson LO, Sandmark J, Castaldo M, Dekker N, Karlsson U, Hurt-Camejo E, ACS Med Chem Lett. 2016 Aug 9;7(10):884-889. eCollection 2016 Oct 13. PMID:27774123 |
Data retrieval |
View 5G3M in 3D |
Visual 3D analysis of 5G3M |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5G3M |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |